Estimating Benefits of Therapy in Crohn’s Disease in Terms of Indirect Costs

Estimating Benefits of Therapy in Crohn’s Disease in Terms of Indirect Costs

Saved in:

Bibliographic Details
Main Author:	Subrata Ghosh
Format:	Article
Language:	English
Published:	Wiley 2011-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2011/310417
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Crohn’s Disease: The Benefits of Extensive Surgery
by: Bruce G Wolff
Published: (1993-01-01)

Exercise and Crohn’s Disease: Speculations on Potential Benefits
by: Victor Ng, et al.
Published: (2006-01-01)

Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
by: Dustin E Loomes, et al.
Published: (2011-01-01)

Transperineal Ultrasonography in Perianal Crohn Disease: A Valuable Imaging Modality
by: Emily K Wright, et al.
Published: (2015-01-01)

Methodological considerations for estimating indirect costs in children and adolescents with chronic conditions: a scoping review
by: Anne Kitschen, et al.
Published: (2025-01-01)

Medical Therapy of Steroid-Resistant Crohn's Disease
by: Bruce E Sands
Published: (2000-01-01)

Antibiotic Therapy for Crohn’s Disease: A Review
by: Simon Lal, et al.
Published: (2006-01-01)

Enteral Nutrition in Crohn’s Disease: An Underused Therapy
by: S. Kansal, et al.
Published: (2013-01-01)

Long-Term Clinical Behavior of Jejunoileal Involvement in Crohn’s Disease
by: Hugh J Freeman
Published: (2005-01-01)

The effect of maintenance therapy on Crohn’s disease clinical outcomes
by: O. B. Schukina, et al.
Published: (2018-08-01)

FEATURES OF ACCOUNTING AND INDIRECT COSTS SHARING IN PRODUCTION IN THE PHARMACEUTICAL INDUSTRY
by: N. Ershova, et al.
Published: (2016-01-01)

The Social Cost-Benefit Analysis as Estimation Methodology: Case Study for Infrastructure Projects
by: Samanta Petohleb Černeha, et al.
Published: (2013-06-01)

Intestinal Tuberculosis Masquerading as Crohn’s Disease? A Case of Disseminated Tuberculosis after Anti-TNF Therapy for Suspected Crohn’s Disease
by: Alexander P. Abadir, et al.
Published: (2019-01-01)

Clinical Benefits and Adverse Effects of Vonoprazan in Long-Term Maintenance Therapy
by: Jin Hee Noh
Published: (2025-01-01)

Costs and Benefits of Vegetable Gardening
by: Kevin Athearn, et al.
Published: (2021-03-01)

Costs and Benefits of Vegetable Gardening
by: Kevin Athearn, et al.
Published: (2021-03-01)

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn’s Disease
by: Min Seob Kwak, et al.
Published: (2018-01-01)

Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy
by: George Chigozie Njoku, et al.
Published: (2025-03-01)

Advances in Our Understanding of the Pathogenesis of Celiac Disease
by: Subrata Ghosh
Published: (2011-01-01)

Clinical Quality Indicators in Inflammatory Bowel Disease
by: Subrata Ghosh
Published: (2014-01-01)

Management of Crohn’s Disease
by: MRB Keighley
Published: (1993-01-01)

Recurrence in Crohn’s Disease
by: Adrian J Greenstein
Published: (1993-01-01)

Funding the New Biologics – CCOHTA Report on the Cost Effectiveness of Infliximab for Crohn’s Disease: Pearls and Pitfalls
by: John K Marshall
Published: (2002-01-01)

Short-Term Efficacy of Exclusive Enteral Nutrition in Pediatric Crohn’s Disease: Practice in China
by: Youyou Luo, et al.
Published: (2015-01-01)

Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn’s Disease
by: Youyou Luo, et al.
Published: (2017-01-01)

Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients
by: Marina Mauro, et al.
Published: (2007-01-01)

Costs and benefits of business information security
by: N. S. Kozyr
Published: (2023-12-01)

Estimating the Impact and Cost of the WHO 2010 Recommendations for Antiretroviral Therapy
by: John Stover, et al.
Published: (2011-01-01)

Biologics in Paediatric Crohn's Disease
by: Oliver Gouldthorpe, et al.
Published: (2011-01-01)

Granulomatous Osteonecrosis in Crohn’s Disease
by: Hugh J Freeman, et al.
Published: (2000-01-01)

Nutrition and Crohn's Disease: An Overview
by: C Ó'Moráin
Published: (1990-01-01)

Crohn’s Disease: Advise and Consent
by: Bruce E Sands, et al.
Published: (2007-01-01)

Meckel's Diverticulum in Crohn's Disease
by: Hugh J Freeman
Published: (2001-01-01)

Preventing Relapse in Crohn’s Disease
by: Jean-Pierre Gendre
Published: (1993-01-01)

Gastroduodenal form of Crohn's disease
by: I. V. Mayev, et al.
Published: (2015-10-01)

Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus
by: Ignacio Marin-Jimenez, et al.
Published: (2024-01-01)

Successful Therapy of Refractory Erythema Nodosum Associated with Crohn's Disease Using Potassium Iodide
by: John K Marshall, et al.
Published: (1997-01-01)

CMV Ileitis: To Treat or Not to Treat? Implications of Initiating Biologic Therapy for Concurrent Crohn’s Disease
by: Kendra T. Stilwell, et al.
Published: (2019-01-01)

Biology of Inflammation in Crohn's Disease: Mechanisms of Action of Anti-TNF-αAlpha Therapy
by: Stephan R Targan
Published: (2000-01-01)

Patients’ Educational Program Could Improve Azathioprine Adherence in Crohn’s Disease Maintenance Therapy
by: Lei Wang, et al.
Published: (2020-01-01)